An Orthogonal Array Optimization of Lipid-like Nanoparticles for MRNA Delivery in Vivo

Overview

Journal Nano Lett

Publisher American Chemical Society

Specialty Biotechnology

Date 2015 Nov 4

PMID 26529392

Citations 106

Authors

Bin Li

Xiao Luo

Binbin Deng

Junfeng Wang

David W McComb

Yimin Shi

Karin M L Gaensler

Xu Tan

Amy L Dunn

Bryce A Kerlin

Yizhou Dong

Affiliations

Soon will be listed here.

Abstract

Systemic delivery of mRNA-based therapeutics remains a challenging issue for preclinical and clinical studies. Here, we describe new lipid-like nanoparticles (TT-LLNs) developed through an orthogonal array design, which demonstrates improved delivery efficiency of mRNA encoding luciferase in vitro by over 350-fold with significantly reduced experimental workload. One optimized TT3 LLN, termed O-TT3 LLNs, was able to restore the human factor IX (hFIX) level to normal physiological values in FIX-knockout mice. Consequently, these mRNA based nanomaterials merit further development for therapeutic applications.

Citing Articles

Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system.

Wang C, Xue Y, Markovic T, Li H, Wang S, Zhong Y Nat Mater. 2025; .

PMID: 39962245 DOI: 10.1038/s41563-024-02114-5.

Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer.

Huang F, Li K, Chen Z, Cui Z, Hankey W, Fang K Oncogene. 2024; 44(8):481-493.

PMID: 39613933 DOI: 10.1038/s41388-024-03239-2.

Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery.

Haque M, Shrestha A, Mikelis C, Mattheolabakis G Int J Pharm X. 2024; 8:100283.

PMID: 39309631 PMC: 11415597. DOI: 10.1016/j.ijpx.2024.100283.

Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies.

Huang X, Ma Y, Ma G, Xia Y Research (Wash D C). 2024; 7:0370.

PMID: 38894715 PMC: 11185168. DOI: 10.34133/research.0370.

Representations of lipid nanoparticles using large language models for transfection efficiency prediction.

Moayedpour S, Broadbent J, Riahi S, Bailey M, V Thu H, Dobchev D Bioinformatics. 2024; 40(7).

PMID: 38810107 PMC: 11629694. DOI: 10.1093/bioinformatics/btae342.

References

Dong Y, Love K, Dorkin J, Sirirungruang S, Zhang Y, Chen D . Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc Natl Acad Sci U S A. 2014; 111(11):3955-60. PMC: 3964096. DOI: 10.1073/pnas.1322937111. View

Dong Y, Eltoukhy A, Alabi C, Khan O, Veiseh O, Dorkin J . Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo. Adv Healthc Mater. 2014; 3(9):1392-7. PMC: 4160381. DOI: 10.1002/adhm.201400054. View

Pascolo S . Vaccination with messenger RNA (mRNA). Handb Exp Pharmacol. 2007; (183):221-35. DOI: 10.1007/978-3-540-72167-3_11. View

Rittig S, Haentschel M, Weimer K, Heine A, Muller M, Brugger W . Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients. Mol Ther. 2010; 19(5):990-9. PMC: 3098631. DOI: 10.1038/mt.2010.289. View

Broaders K, Pastine S, Grandhe S, Frechet J . Acid-degradable solid-walled microcapsules for pH-responsive burst-release drug delivery. Chem Commun (Camb). 2010; 47(2):665-7. DOI: 10.1039/c0cc04190d. View

van Hylckama Vlieg A, Van der Linden I, Bertina R, Rosendaal F . High levels of factor IX increase the risk of venous thrombosis. Blood. 2000; 95(12):3678-82. View

Day S, Reeve J, Myers D, Fay W . Murine thrombosis models. Thromb Haemost. 2004; 92(3):486-94. View

Phua K, Leong K, Nair S . Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J Control Release. 2013; 166(3):227-33. PMC: 3594075. DOI: 10.1016/j.jconrel.2012.12.029. View

Monahan P, White 2nd G . Hemophilia gene therapy: update. Curr Opin Hematol. 2002; 9(5):430-6. DOI: 10.1097/00062752-200209000-00007. View

10.

Barzel A, Paulk N, Shi Y, Huang Y, Chu K, Zhang F . Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature. 2014; 517(7534):360-4. PMC: 4297598. DOI: 10.1038/nature13864. View

11.

Love K, Mahon K, Levins C, Whitehead K, Querbes W, Dorkin J . Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A. 2010; 107(5):1864-9. PMC: 2804742. DOI: 10.1073/pnas.0910603106. View

12.

Akinc A, Zumbuehl A, Goldberg M, Leshchiner E, Busini V, Hossain N . A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol. 2008; 26(5):561-9. PMC: 3014085. DOI: 10.1038/nbt1402. View

13.

Ryan D, Papamichail D . Rational design of orthogonal libraries of protein coding genes. ACS Synth Biol. 2013; 2(5):237-44. DOI: 10.1021/sb300086d. View

14.

Mishra S, Webster P, Davis M . PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol. 2004; 83(3):97-111. DOI: 10.1078/0171-9335-00363. View

15.

Weide B, Carralot J, Reese A, Scheel B, Eigentler T, Hoerr I . Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother. 2008; 31(2):180-8. DOI: 10.1097/CJI.0b013e31815ce501. View

16.

Weide B, Pascolo S, Scheel B, Derhovanessian E, Pflugfelder A, Eigentler T . Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. J Immunother. 2009; 32(5):498-507. DOI: 10.1097/CJI.0b013e3181a00068. View

17.

Chen D, Love K, Chen Y, Eltoukhy A, Kastrup C, Sahay G . Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J Am Chem Soc. 2012; 134(16):6948-51. DOI: 10.1021/ja301621z. View

18.

Otsuka H, Nagasaki Y, Kataoka K . PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003; 55(3):403-19. DOI: 10.1016/s0169-409x(02)00226-0. View

19.

Zhan J, Zheng K, Zhu K, Bi C, Zhang W, Du C . Chemical and biological assessment of Angelicae Sinensis Radix after processing with wine: an orthogonal array design to reveal the optimized conditions. J Agric Food Chem. 2011; 59(11):6091-8. DOI: 10.1021/jf200728e. View

20.

Wang Y, Su H, Yang Y, Hu Y, Zhang L, Blancafort P . Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. Mol Ther. 2012; 21(2):358-67. PMC: 3594035. DOI: 10.1038/mt.2012.250. View